JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 22, 2004; DOI: 10.1124/jpet.104.080424


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.104.080424v1
313/1/78    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kostenis, E.
Right arrow Articles by Milligan, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kostenis, E.
Right arrow Articles by Milligan, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*GLYCINE


Received for publication November 10, 2004.
Revised December 16, 2004.
Accepted for publication December 17, 2004.

A highly conserved glycine within linker I and the extreme C-terminus of G protein {alpha} subunits interact cooperatively in switching GPCR-to-effector specificity

Evi Kostenis 1*, Lene Martini 2, James Ellis 3, Maria Waldhoer 2, Arne Heydorn 4, Mette M Rosenkilde 4, Pia K. Norregaard 1, Rasmus Jorgensen 1, Jennifer L Whistler 2, Graeme Milligan 3

1 7TM Pharma 2 UCSF - Ernest Gallo Research Institute 3 University of Glasgow 4 University of Copenhagen

* Address correspondence to: E-mail: ek{at}7tm.com

Abstract

Numerous studies have attested to the importance of the extreme C-terminus of G protein {alpha} subunits in determining their selectivity of receptor recognition. We have previously reported that a highly conserved glycine residue within linker I is important for constraining the fidelity of receptor recognition by G{alpha}q proteins (Heydorn et al., 2004). Herein, we explored whether both modules (linker I and extreme C-terminus) interact cooperatively in switching GPCR-to-effector specificity and created as models mutant G{alpha}q proteins in which glycine was replaced with various amino acids and the C- terminal five G{alpha}q residues with the corresponding G{alpha}i or G{alpha}s sequence. Coupling properties of the mutated G{alpha}q proteins were determined following coexpression with a panel of thirteen Gi-and Gs-selective receptors and compared with those of G{alpha} proteins modified in only one module. G{alpha} proteins modified in both modules are significantly more efficacious in channelling non-Gq selective receptors to Gq-mediated signalling events as compared with those containing each module alone. Additive effects of both modules were observed even if individual modules lacked an effect on GPCR-to-effector specificity. Dually modified G{alpha} proteins were also superior in conferring high affinity agonist sites onto a coexpressed GPCR in the absence, but not in the presence of guanine nucleotides. Together, our data suggest that receptor-G protein coupling selectivity involves cooperative interactions between the extreme C- terminus and linker I of G{alpha} proteins and that distinct determinants of selectivity exist for individual receptors.


Key words: G alpha q, G protein, GPCR, chimeric Galpha protein, promiscuous G protein, signal transduction


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
M. Vrecl, P. K. Norregaard, D. L.C. Almholt, L. Elster, A. Pogacnik, and A. Heding
{beta}-Arrestin-Based Bret2 Screening Assay for the "Non"-{beta}-Arrestin Binding CB1 Receptor
J Biomol Screen, April 1, 2009; 14(4): 371 - 380.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
R. Schroder, N. Merten, J. M. Mathiesen, L. Martini, A. Kruljac-Letunic, F. Krop, A. Blaukat, Y. Fang, E. Tran, T. Ulven, et al.
The C-terminal Tail of CRTH2 Is a Key Molecular Determinant That Constrains G{alpha}i and Downstream Signaling Cascade Activation
J. Biol. Chem., January 9, 2009; 284(2): 1324 - 1336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Stoddart, N. J. Smith, L. Jenkins, A. J. Brown, and G. Milligan
Conserved Polar Residues in Transmembrane Domains V, VI, and VII of Free Fatty Acid Receptor 2 and Free Fatty Acid Receptor 3 Are Required for the Binding and Function of Short Chain Fatty Acids
J. Biol. Chem., November 21, 2008; 283(47): 32913 - 32924.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Krietsch, M. S. Fernandes, J. Kero, R. Losel, M. Heyens, E. W.-F. Lam, I. Huhtaniemi, J. J. Brosens, and B. Gellersen
Human Homologs of the Putative G Protein-Coupled Membrane Progestin Receptors (mPR{alpha}, {beta}, and {gamma}) Localize to the Endoplasmic Reticulum and Are Not Activated by Progesterone
Mol. Endocrinol., December 1, 2006; 20(12): 3146 - 3164.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Mathiesen, A. Christopoulos, T. Ulven, J. F. Royer, M. Campillo, A. Heinemann, L. Pardo, and E. Kostenis
On the Mechanism of Interaction of Potent Surmountable and Insurmountable Antagonists with the Prostaglandin D2 Receptor CRTH2
Mol. Pharmacol., April 1, 2006; 69(4): 1441 - 1453.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. M. Mathiesen, T. Ulven, L. Martini, L. O. Gerlach, A. Heinemann, and E. Kostenis
Identification of Indole Derivatives Exclusively Interfering with a G Protein-Independent Signaling Pathway of the Prostaglandin D2 Receptor CRTH2
Mol. Pharmacol., August 1, 2005; 68(2): 393 - 402.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.